Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(23%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
12
92%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (7.7%)
N/A12 (92.3%)

Trials by Status

active_not_recruiting18%
unknown323%
completed754%
recruiting215%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
13